Literature DB >> 12798016

Frequencies of 32 base pair deletion of the (Delta 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis.

Gérard Lucotte1.   

Abstract

The CCR5 gene encodes for the co-receptor for the major macrophage-tropics strains of human immunodeficiency virus (HIV-1), and a mutant allele of this gene (Delta 32) provide to homozygotes a strong resistance against infection by HIV. The frequency of the Delta 32 allele was investigated in 40 populations of 8842 non-infected subjects coming from Europe, the Middle-East and North Africa. A clear north-south decreasing gradient was evident for Delta 32 frequencies, with a significant correlation coefficient (r=0.83). The main frequency value of Delta 32 for Sweden, Norway, Denmark, Finland and Iceland (0.134) is significantly (chi(2)=63.818, P<0.001) highest than the Delta 32 mean value, indicating that probably the Vikings might have been instrumental in disseminating the Delta 32 allele during the eighth to the tenth centuries during historical times. Possibly variola virus has discriminated the Delta 32 carriers in Europe since the eighth century AD, explaining the high frequency of the Delta 32 allele in Europe today.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12798016     DOI: 10.1016/s1567-1348(02)00027-8

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  21 in total

1.  Prevalence of CCR5 Gene 32-Basepair Deletion in Populations of Slavic Origin.

Authors:  Mario Poljak; Polona J Maver; Katja Seme
Journal:  Croat Med J       Date:  2006-04       Impact factor: 1.351

2.  Historic exposure to plague and present-day frequency of CCR5del32 in two isolated island communities of Dalmatia, Croatia.

Authors:  Mladen Smoljanović; Smiljana Ristić; Caroline Hayward
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

3.  The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.

Authors:  Emese Juhász; Judit Béres; Szilvia Kanizsai; Károly Nagy
Journal:  Pathol Oncol Res       Date:  2011-06-11       Impact factor: 3.201

4.  Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; Mi Kwon; Gabriela Rodriguez-Macias; Jorge Gayoso; Javier Anguita; Ismael Buño; Juan Berenguer; José L Díez-Martín
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-24       Impact factor: 2.205

5.  Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.

Authors:  Florian Hladik; Huanliang Liu; Emily Speelmon; Devon Livingston-Rosanoff; Sean Wilson; Polachai Sakchalathorn; Yon Hwangbo; Benjamin Greene; Tuofu Zhu; M Juliana McElrath
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.

Authors:  G Gonzalez; Ss Park; Dw Chen; S Armitage; Ej Shpall; Rr Behringer
Journal:  HIV Med       Date:  2011-03-06       Impact factor: 3.180

7.  Historic, demographic, and genetic evidence for increased population frequencies of CCR5Delta32 mutation in Croatian Island isolates after lethal 15th century epidemics.

Authors:  Zrinka Biloglav; Lina Zgaga; Mladen Smoljanović; Caroline Hayward; Ozren Polasek; Ivana Kolcić; Veronique Vitart; Tatijana Zemunik; Vesna Boraska; Vesela Torlak; Rosanda Mulić; Darko Ropac; Ivica Grković; Diana Rudan; Smiljana Ristić; Maja Barbalić; Harry Campbell; Alan F Wright; Igor Rudan
Journal:  Croat Med J       Date:  2009-02       Impact factor: 1.351

8.  Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals.

Authors:  Rui André Saraiva Raposo; Mohamed Abdel-Mohsen; Sara J Holditch; Peter J Kuebler; Rex G Cheng; Emily M Eriksson; Wilson Liao; Satish K Pillai; Douglas F Nixon
Journal:  J Leukoc Biol       Date:  2013-08-08       Impact factor: 4.962

9.  Chemokine polymorphisms and lymphoma: a pooled analysis.

Authors:  Paige M Bracci; Christine F Skibola; Lucia Conde; Eran Halperin; Tracy Lightfoot; Alex Smith; Randi A Paynter; Danica R Skibola; Luz Agana; Eve Roman; Eleanor Kane; John K Wiencke
Journal:  Leuk Lymphoma       Date:  2010-03

10.  Transplantation of selected or transgenic blood stem cells - a future treatment for HIV/AIDS?

Authors:  Gero Hütter; Thomas Schneider; Eckhard Thiel
Journal:  J Int AIDS Soc       Date:  2009-06-28       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.